» Articles » PMID: 28795206

Children and Adolescents with Cystic Fibrosis Display Moderate Bone Microarchitecture Abnormalities: Data from High-resolution Peripheral Quantitative Computed Tomography

Overview
Journal Osteoporos Int
Date 2017 Aug 11
PMID 28795206
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Cystic fibrosis-related bone disease (CFBD) may alter bone health, ultimately predisposing patients to bone fractures. Our aim was to assess bone microstructure using high-resolution peripheral quantitative tomography (HR-pQCT) in a cohort of children and teenagers with CF in comparison to age-, puberty-, and gender-matched healthy volunteers (HVs).

Methods: In this single-center, prospective, cross-sectional study, we evaluated the HR-pQCT bone parameters of CF patients and compared them to those of the healthy volunteers.

Results: At a median age of 15.4 [range, 10.5-17.9] years, 37 CF patients (21 boys) with 91% [range, 46-138%] median forced expiratory volume in 1 s were included. At the ultradistal tibia, CF patients had a smaller bone cross-sectional area (579 [range, 399-1087] mm) than HVs (655 [range, 445-981] mm) (p = 0.027), related to a decreased trabecular area, without any significant differences for height. No other differences were found (trabecular number, separation, thickness, or distribution) at the radial or tibial levels. Bone structure was different in patients receiving ursodeoxycholic acid and those bearing two F508del mutations.

Conclusion: In our cohort of children and teenagers with good nutritional and lung function status, bone microstructure evaluated with HR-pQCT was not severely affected. Minimal microstructure abnormalities observed at the tibial level may be related to the cystic fibrosis transmembrane conductance regulator defect alone; the long-term consequences of such impairment will require further evaluation.

Citing Articles

Impaired bone mineral density and microarchitecture in female adolescents with IgE-mediated cow's milk allergy.

Yonamine G, Domiciano D, Takayama L, Castro A, Pereira R, Pastorino A Arch Osteoporos. 2024; 19(1):40.

PMID: 38773042 DOI: 10.1007/s11657-024-01396-1.


Cystic Fibrosis Bone Disease: The Interplay between CFTR Dysfunction and Chronic Inflammation.

Fonseca O, Gomes M, Amorim M, Gomes A Biomolecules. 2023; 13(3).

PMID: 36979360 PMC: 10046889. DOI: 10.3390/biom13030425.


An update on methods for assessing bone quality and health in Cystic fibrosis.

Williams K, Darukhanavala A, Hicks R, Kelly A J Clin Transl Endocrinol. 2022; 27:100281.

PMID: 34984171 PMC: 8693345. DOI: 10.1016/j.jcte.2021.100281.


The Effects of Ivacaftor on Bone Density and Microarchitecture in Children and Adults with Cystic Fibrosis.

Putman M, Greenblatt L, Bruce M, Joseph T, Lee H, Sawicki G J Clin Endocrinol Metab. 2020; 106(3):e1248-e1261.

PMID: 33258950 PMC: 7947772. DOI: 10.1210/clinem/dgaa890.


Guidelines for the assessment of bone density and microarchitecture in vivo using high-resolution peripheral quantitative computed tomography.

Whittier D, Boyd S, Burghardt A, Paccou J, Ghasem-Zadeh A, Chapurlat R Osteoporos Int. 2020; 31(9):1607-1627.

PMID: 32458029 PMC: 7429313. DOI: 10.1007/s00198-020-05438-5.


References
1.
Sermet-Gaudelus I, Souberbielle J, Ruiz J, Vrielynck S, Heuillon B, Azhar I . Low bone mineral density in young children with cystic fibrosis. Am J Respir Crit Care Med. 2007; 175(9):951-7. DOI: 10.1164/rccm.200606-776OC. View

2.
Sands D, Mielus M, Umlawska W, Lipowicz A, Oralewska B, Walkowiak J . Evaluation of factors related to bone disease in Polish children and adolescents with cystic fibrosis. Adv Med Sci. 2015; 60(2):315-20. DOI: 10.1016/j.advms.2015.05.002. View

3.
Stahl M, Holfelder C, Kneppo C, Kieser M, Kasperk C, Schoenau E . Multiple prevalent fractures in relation to macroscopic bone architecture in patients with cystic fibrosis. J Cyst Fibros. 2016; 17(1):114-120. DOI: 10.1016/j.jcf.2016.06.004. View

4.
Le Heron L, Guillaume C, Velard F, Braux J, Touqui L, Moriceau S . Cystic fibrosis transmembrane conductance regulator (CFTR) regulates the production of osteoprotegerin (OPG) and prostaglandin (PG) E2 in human bone. J Cyst Fibros. 2009; 9(1):69-72. DOI: 10.1016/j.jcf.2009.11.005. View

5.
De Schepper J, Roggen I, Van Biervliet S, Robberecht E, Gies I, De Waele K . Comparative bone status assessment by dual energy X-ray absorptiometry, peripheral quantitative computed tomography and quantitative ultrasound in adolescents and young adults with cystic fibrosis. J Cyst Fibros. 2011; 11(2):119-24. DOI: 10.1016/j.jcf.2011.10.004. View